Comparing CCI and POSSUM for Predicting Oncogynecologic Surgery Complications

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18+
SponsorMahidol University

About this trial

With the global rates of gynecologic cancers on the rise, optimizing perioperative care is imperative. Accurate risk prediction is essential for enhancing patient care, directing preoperative interventions, and facilitating informed decision-making in oncology. This research compares two widely-used risk assessment tools: the Charlson Comorbidity Index (CCI) and the Physiological and Operative Severity Score for the enUmeration of Mortality and Morbidity (POSSUM), in predicting perioperative outcomes. The CCI predominantly addresses comorbidities, providing simplicity and broad applicability, while POSSUM incorporates both physiological and operative factors for a more comprehensive risk assessment. Despite their application across various surgical specialties, the specific utility of these tools in onco-gynecologic surgery remains insufficiently explored. The study aims to evaluate the effectiveness of CCI and POSSUM in predicting perioperative complications, with a focus on the incidence of these complications, length of hospital stay, and 30-day mortality. The implementation of these risk tools may enhance multidisciplinary risk management, thus improving patient outcomes in gynecologic oncology surgery.

Eligibility criteria

Qualifiers

Age > 18 years

Patient underwent elective onco-gynecologic surgery

Disqualifiers

Patient required emergency surgery from any indication

Patient chart that not contained primary outcome data eg. absent of the anesthetic record

Trial design

Treatments tested in this trial

  • CCI score
  • POSSUM score

Treatment groups

No treatment groups listed

Sponsors and collaborators